Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

Allen Wilbanks finds himself at SABCS 2023, where he engages in a discussion with Dr.…

By. Ruth O’Regan MD Date: 12/07/2023In an interview, Ruth O’Regan MD addresses questions related to the…

By. Terry Mamounas Date: 12/07/2023In a collaborative study between NVP and RT, led by oncologist…

Allen Wilbanks stood alongside Alina Hamilton, PhD, at the SABCS 2023 event, where they delved…

By. Neil Carleton, MD Date. 12/07/2023 In the interview with Neil Carleton, MD, the discussion revolved…

At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…

By: Melinda Telli, MD, Date: 12/9/2023 At the SABCS 2023 conference, we had the privilege…

In the groundbreaking study conducted by Bruce Feinberg,DO, Chief Medical Officer at Cardinal Health, the…

Under the lights of ASH 2023, the microphone poised to capture insights, Dr. Lorenzo Falchi,…